Insurers File Antitrust Suit Vs. Purdue Over Oxycontin Patents
The complaint alleges that Purdue obtained patents by misleading the U.S. Patent and Trademark Office about the effectiveness of Oxycontin at low doses. The drug manufacturer reaped "excess profits" of more than $1 billion, the lawsuit says.
The lawsuit, filed recently in U.S. District Court in New York, seeks restitution of excess profits of an unspecified...
To view the full article, register now.